NCT00210535View on ClinicalTrials.gov

A Study of the Effectiveness and Safety of Topiramate for the Prevention of Migraine Attacks in Children

PHASE3CompletedINTERVENTIONAL

Enrollment

110

Participants

Timeline

Start Date

June 30, 2005

Study Completion Date

November 30, 2006

Conditions

MigraineVascular Headaches

Interventions

DRUG

Topiramate; Placebo

All Listed Sponsors

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00210535 - A Study of the Effectiveness and Safety of Topiramate for the Prevention of Migraine Attacks in Children | Biotech Hunter | Biotech Hunter